Circadian Rhythms in AD pathogenesis: A Critical Appraisal
- PMID: 29308355
- PMCID: PMC5754029
- DOI: 10.1007/s40675-017-0072-5
Circadian Rhythms in AD pathogenesis: A Critical Appraisal
Abstract
Purpose of the review: A wide array of sleep and circadian deficits have been observed in patients with Alzheimer's Disease (AD). However, the vast majority of these studies have focused on later-stage AD, and do not shed light on the possibility that circadian dysfunction contributes to AD pathogenesis. The goal of this review it to examine the evidence supporting or refuting the hypothesis that circadian dysfunction plays an important role in early AD pathogenesis or AD risk in humans.
Recent findings: Few studies have addressed the role of the circadian system in very early AD, or prior to AD diagnosis. AD appears to have a long presymtomatic phase during which pathology is present but cognition remains normal. Studies evaluating circadian function in cognitively-normal elderly or early-stage AD have thus far not incorporated AD biomarkers. Thus, the cause-and-effect relationship between circadian dysfunction and early-stage AD remains unclear.
Summary: Circadian dysfunction becomes apparent in AD as dementia progresses, but it is unknown at which point in the pathogenic process rhythms begin to deteriorate. Further, it is unknown if exposure to circadian disruption in middle age increases AD risk later in life. This review address gaps in current knowledge on this topic, and proposes several critical directions for future research which might help to clarify the potential pathogenic role of circadian clock dysfunction in AD.
Keywords: Alzheimer’s Disease; amyloid; circadian; clock genes; neurodegeneration.
Conflict of interest statement
Conflicts of Interest: Erik S. Musiek reports grants from NIH, Alzheimer’s Association, Coins for Alzheimer’s Trust, during the conduct of the study; personal fees from Eisai Pharmaceuticals.
Figures
Similar articles
-
Circadian and sleep dysfunction in Alzheimer's disease.Ageing Res Rev. 2020 Jul;60:101046. doi: 10.1016/j.arr.2020.101046. Epub 2020 Apr 16. Ageing Res Rev. 2020. PMID: 32171783 Review.
-
Pro: Alzheimer's disease and circadian dysfunction: chicken or egg?Alzheimers Res Ther. 2012 Aug 13;4(4):25. doi: 10.1186/alzrt128. eCollection 2012. Alzheimers Res Ther. 2012. PMID: 22883711 Free PMC article.
-
Dysfunction of circadian and sleep rhythms in the early stages of Alzheimer's disease.Acta Physiol (Oxf). 2023 Jun;238(2):e13970. doi: 10.1111/apha.13970. Epub 2023 Apr 18. Acta Physiol (Oxf). 2023. PMID: 37000425 Review.
-
Circadian dysfunction and Alzheimer's disease - An updated review.Aging Med (Milton). 2022 Aug 15;6(1):71-81. doi: 10.1002/agm2.12221. eCollection 2023 Mar. Aging Med (Milton). 2022. PMID: 36911088 Free PMC article.
-
Manipulations of amyloid precursor protein cleavage disrupt the circadian clock in aging Drosophila.Neurobiol Dis. 2015 May;77:117-26. doi: 10.1016/j.nbd.2015.02.012. Epub 2015 Mar 10. Neurobiol Dis. 2015. PMID: 25766673 Free PMC article.
Cited by
-
Outdoor nighttime light exposure (light pollution) is associated with Alzheimer's disease.Front Neurosci. 2024 Sep 6;18:1378498. doi: 10.3389/fnins.2024.1378498. eCollection 2024. Front Neurosci. 2024. PMID: 39308948 Free PMC article.
-
Integrated Transcriptomics and Network Analysis Identified Altered Neural Mechanisms in Frontal Aging Brain-Associated Alzheimer's Disease.Biochem Genet. 2024 Aug;62(4):2382-2398. doi: 10.1007/s10528-023-10549-9. Epub 2023 Nov 7. Biochem Genet. 2024. PMID: 37934339
-
Spatially coordinated collective phosphorylation filters spatiotemporal noises for precise circadian timekeeping.iScience. 2023 Apr 1;26(4):106554. doi: 10.1016/j.isci.2023.106554. eCollection 2023 Apr 21. iScience. 2023. PMID: 37123226 Free PMC article.
-
Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer's disease.Acta Neuropathol Commun. 2023 Mar 31;11(1):55. doi: 10.1186/s40478-023-01529-6. Acta Neuropathol Commun. 2023. PMID: 37004084 Free PMC article.
-
Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin.Int J Mol Sci. 2023 Feb 3;24(3):3022. doi: 10.3390/ijms24033022. Int J Mol Sci. 2023. PMID: 36769340 Free PMC article. Review.
References
-
- Alzheimer’s Association. Alzhiemer’s Disease Facts and Figures. Alzheimers Dement. 2015;11:332–384. - PubMed
-
- Holth JK, Patel TK, Holtzman DM. Sleep in Alzheimer’s Disease - Beyond Amyloid. Neurobiol Sleep Circad Rhythym. 2016 http://dx.doi.org/10.1016/j.nbscr.2016.08.002. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials